Click for best price
Parkinson's Disease PD Drugs Market Size, Share 2022
Market Analysis and Insights: Global Parkinson's Disease PD Drugs Market
The global Parkinson's Disease PD Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Parkinson's Disease PD Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Parkinson's Disease PD Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Parkinson's Disease PD Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Parkinson's Disease PD Drugs market.
Global Parkinson's Disease PD Drugs Scope and Market Size
Parkinson's Disease (PD) Drugs market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Parkinson's Disease (PD) Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Parkinson's Disease (PD) Drugs market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Dopamine Agonist
Monoamine Oxidase Inhibitors
Acetylcholinesterase Inhibitors
Glutamate Inhibitors
Segment by Application
Hospital
Family
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Boehringer Ingelheim
GlaxoSmithKline
Novartis
Teva Pharmaceutical Industries
AbbVie
Abital Pharma
Addex Therapeutics
Biogen
Eisai
Eli Lilly
F. Hoffmann-La Roche
H. Lundbeck
Impax Laboratories
Kyowa Hakko Kirin
Otsuka Pharmaceutical
Pfizer
The information for each competitor/Company Profile includes:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The content of the study subjects includes a total of 15 chapters:
Chapter 1, describes Parkinson's Disease PD Drugs product scope, market overview, market opportunities, market driving force, and market risks.
Chapter 2, profiles the top manufacturers of Parkinson's Disease PD Drugs, with price, sales, revenue, and global market share of Parkinson's Disease PD Drugs from 2019 to 2022.
Chapter 3, the Parkinson's Disease PD Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parkinson's Disease PD Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.
Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Parkinson's Disease PD Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Parkinson's Disease PD Drugs.
Chapter 13, 14, and 15, to describe Parkinson's Disease PD Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Key Indicators Analysed:
- Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
- Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
- Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
- Opportunities and Drivers: Identifying the Growing Demands and New Technology
- Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Reasons to Purchase this Report:
- Estimates 2022-2027 2021-2025 Parkinson's Disease PD Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
- 1-year analyst support, along with the data support in excel format.
Research Methodology:
The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.
| Report Attributes |
Report Details |
| Report Title |
Global and United States Parkinson's Disease (PD) Drugs Market Report & Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
111 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Study Coverage
1.1 Parkinson's Disease (PD) Drugs Product Introduction
1.2 Global Parkinson's Disease (PD) Drugs Outlook 2017 VS 2022 VS 2028
1.2.1 Global Parkinson's Disease (PD) Drugs Sales in US$ Million for the Year 2017-2028
1.2.2 Global Parkinson's Disease (PD) Drugs Sales in Volume for the Year 2017-2028
1.3 United States Parkinson's Disease (PD) Drugs Outlook 2017 VS 2022 VS 2028
1.3.1 United States Parkinson's Disease (PD) Drugs Sales in US$ Million for the Year 2017-2028
1.3.2 United States Parkinson's Disease (PD) Drugs Sales in Volume for the Year 2017-2028
1.4 Parkinson's Disease (PD) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Parkinson's Disease (PD) Drugs in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Parkinson's Disease (PD) Drugs Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Parkinson's Disease (PD) Drugs Market Dynamics
1.5.1 Parkinson's Disease (PD) Drugs Industry Trends
1.5.2 Parkinson's Disease (PD) Drugs Market Drivers
1.5.3 Parkinson's Disease (PD) Drugs Market Challenges
1.5.4 Parkinson's Disease (PD) Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Parkinson's Disease (PD) Drugs Market Segment by Type
2.1.1 Dopamine Agonist
2.1.2 Monoamine Oxidase Inhibitors
2.1.3 Acetylcholinesterase Inhibitors
2.1.4 Glutamate Inhibitors
2.2 Global Parkinson's Disease (PD) Drugs Market Size by Type
2.2.1 Global Parkinson's Disease (PD) Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Parkinson's Disease (PD) Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Parkinson's Disease (PD) Drugs Market Size by Type
2.3.1 United States Parkinson's Disease (PD) Drugs Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Parkinson's Disease (PD) Drugs Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Parkinson's Disease (PD) Drugs Market Segment by Application
3.1.1 Hospital
3.1.2 Family
3.2 Global Parkinson's Disease (PD) Drugs Market Size by Application
3.2.1 Global Parkinson's Disease (PD) Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Parkinson's Disease (PD) Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Parkinson's Disease (PD) Drugs Market Size by Application
3.3.1 United States Parkinson's Disease (PD) Drugs Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Parkinson's Disease (PD) Drugs Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Parkinson's Disease (PD) Drugs Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Parkinson's Disease (PD) Drugs Competitor Landscape by Company
4.1 Global Parkinson's Disease (PD) Drugs Market Size by Company
4.1.1 Top Global Parkinson's Disease (PD) Drugs Manufacturers Ranked by Revenue (2021)
4.1.2 Global Parkinson's Disease (PD) Drugs Revenue by Manufacturer (2017-2022)
4.1.3 Global Parkinson's Disease (PD) Drugs Sales by Manufacturer (2017-2022)
4.1.4 Global Parkinson's Disease (PD) Drugs Price by Manufacturer (2017-2022)
4.2 Global Parkinson's Disease (PD) Drugs Concentration Ratio (CR)
4.2.1 Parkinson's Disease (PD) Drugs Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Parkinson's Disease (PD) Drugs in 2021
4.2.3 Global Parkinson's Disease (PD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Parkinson's Disease (PD) Drugs Manufacturing Base Distribution, Product Type
4.3.1 Global Parkinson's Disease (PD) Drugs Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Parkinson's Disease (PD) Drugs Product Type
4.3.3 Date of International Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Parkinson's Disease (PD) Drugs Market Size by Company
4.5.1 Top Parkinson's Disease (PD) Drugs Players in United States, Ranked by Revenue (2021)
4.5.2 United States Parkinson's Disease (PD) Drugs Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Parkinson's Disease (PD) Drugs Sales by Players (2020, 2021 & 2022)
5 Global Parkinson's Disease (PD) Drugs Market Size by Region
5.1 Global Parkinson's Disease (PD) Drugs Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Parkinson's Disease (PD) Drugs Market Size in Volume by Region (2017-2028)
5.2.1 Global Parkinson's Disease (PD) Drugs Sales in Volume by Region: 2017-2022
5.2.2 Global Parkinson's Disease (PD) Drugs Sales in Volume Forecast by Region (2023-2028)
5.3 Global Parkinson's Disease (PD) Drugs Market Size in Value by Region (2017-2028)
5.3.1 Global Parkinson's Disease (PD) Drugs Sales in Value by Region: 2017-2022
5.3.2 Global Parkinson's Disease (PD) Drugs Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Parkinson's Disease (PD) Drugs Market Size YoY Growth 2017-2028
6.1.2 North America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Parkinson's Disease (PD) Drugs Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Parkinson's Disease (PD) Drugs Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Parkinson's Disease (PD) Drugs Market Size YoY Growth 2017-2028
6.3.2 Europe Parkinson's Disease (PD) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Parkinson's Disease (PD) Drugs Market Size YoY Growth 2017-2028
6.4.2 Latin America Parkinson's Disease (PD) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Parkinson's Disease (PD) Drugs Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Parkinson's Disease (PD) Drugs Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Boehringer Ingelheim
7.1.1 Boehringer Ingelheim Corporation Information
7.1.2 Boehringer Ingelheim Description and Business Overview
7.1.3 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Boehringer Ingelheim Parkinson's Disease (PD) Drugs Products Offered
7.1.5 Boehringer Ingelheim Recent Development
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Corporation Information
7.2.2 GlaxoSmithKline Description and Business Overview
7.2.3 GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.2.4 GlaxoSmithKline Parkinson's Disease (PD) Drugs Products Offered
7.2.5 GlaxoSmithKline Recent Development
7.3 Novartis
7.3.1 Novartis Corporation Information
7.3.2 Novartis Description and Business Overview
7.3.3 Novartis Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Novartis Parkinson's Disease (PD) Drugs Products Offered
7.3.5 Novartis Recent Development
7.4 Teva Pharmaceutical Industries
7.4.1 Teva Pharmaceutical Industries Corporation Information
7.4.2 Teva Pharmaceutical Industries Description and Business Overview
7.4.3 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.4.4 Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Products Offered
7.4.5 Teva Pharmaceutical Industries Recent Development
7.5 AbbVie
7.5.1 AbbVie Corporation Information
7.5.2 AbbVie Description and Business Overview
7.5.3 AbbVie Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.5.4 AbbVie Parkinson's Disease (PD) Drugs Products Offered
7.5.5 AbbVie Recent Development
7.6 Abital Pharma
7.6.1 Abital Pharma Corporation Information
7.6.2 Abital Pharma Description and Business Overview
7.6.3 Abital Pharma Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Abital Pharma Parkinson's Disease (PD) Drugs Products Offered
7.6.5 Abital Pharma Recent Development
7.7 Addex Therapeutics
7.7.1 Addex Therapeutics Corporation Information
7.7.2 Addex Therapeutics Description and Business Overview
7.7.3 Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Addex Therapeutics Parkinson's Disease (PD) Drugs Products Offered
7.7.5 Addex Therapeutics Recent Development
7.8 Biogen
7.8.1 Biogen Corporation Information
7.8.2 Biogen Description and Business Overview
7.8.3 Biogen Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.8.4 Biogen Parkinson's Disease (PD) Drugs Products Offered
7.8.5 Biogen Recent Development
7.9 Eisai
7.9.1 Eisai Corporation Information
7.9.2 Eisai Description and Business Overview
7.9.3 Eisai Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Eisai Parkinson's Disease (PD) Drugs Products Offered
7.9.5 Eisai Recent Development
7.10 Eli Lilly
7.10.1 Eli Lilly Corporation Information
7.10.2 Eli Lilly Description and Business Overview
7.10.3 Eli Lilly Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Eli Lilly Parkinson's Disease (PD) Drugs Products Offered
7.10.5 Eli Lilly Recent Development
7.11 F. Hoffmann-La Roche
7.11.1 F. Hoffmann-La Roche Corporation Information
7.11.2 F. Hoffmann-La Roche Description and Business Overview
7.11.3 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.11.4 F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Products Offered
7.11.5 F. Hoffmann-La Roche Recent Development
7.12 H. Lundbeck
7.12.1 H. Lundbeck Corporation Information
7.12.2 H. Lundbeck Description and Business Overview
7.12.3 H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.12.4 H. Lundbeck Products Offered
7.12.5 H. Lundbeck Recent Development
7.13 Impax Laboratories
7.13.1 Impax Laboratories Corporation Information
7.13.2 Impax Laboratories Description and Business Overview
7.13.3 Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.13.4 Impax Laboratories Products Offered
7.13.5 Impax Laboratories Recent Development
7.14 Kyowa Hakko Kirin
7.14.1 Kyowa Hakko Kirin Corporation Information
7.14.2 Kyowa Hakko Kirin Description and Business Overview
7.14.3 Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Kyowa Hakko Kirin Products Offered
7.14.5 Kyowa Hakko Kirin Recent Development
7.15 Otsuka Pharmaceutical
7.15.1 Otsuka Pharmaceutical Corporation Information
7.15.2 Otsuka Pharmaceutical Description and Business Overview
7.15.3 Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Otsuka Pharmaceutical Products Offered
7.15.5 Otsuka Pharmaceutical Recent Development
7.16 Pfizer
7.16.1 Pfizer Corporation Information
7.16.2 Pfizer Description and Business Overview
7.16.3 Pfizer Parkinson's Disease (PD) Drugs Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Pfizer Products Offered
7.16.5 Pfizer Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Parkinson's Disease (PD) Drugs Industry Chain Analysis
8.2 Parkinson's Disease (PD) Drugs Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Parkinson's Disease (PD) Drugs Distributors
8.3 Parkinson's Disease (PD) Drugs Production Mode & Process
8.4 Parkinson's Disease (PD) Drugs Sales and Marketing
8.4.1 Parkinson's Disease (PD) Drugs Sales Channels
8.4.2 Parkinson's Disease (PD) Drugs Distributors
8.5 Parkinson's Disease (PD) Drugs Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Parkinson's Disease (PD) Drugs CAGR in Value, United States VS Global, 2017 VS 2022 VS 2028
Table 2. Parkinson's Disease (PD) Drugs Market Trends
Table 3. Parkinson's Disease (PD) Drugs Market Drivers
Table 4. Parkinson's Disease (PD) Drugs Market Challenges
Table 5. Parkinson's Disease (PD) Drugs Market Restraints
Table 6. Global Parkinson's Disease (PD) Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 7. United States Parkinson's Disease (PD) Drugs Sales by Type: 2017 VS 2022 VS 2028 (US$ Million)
Table 8. Global Parkinson's Disease (PD) Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 9. United States Parkinson's Disease (PD) Drugs Sales by Application: 2017 VS 2022 VS 2028 (US$ Million)
Table 10. Top Parkinson's Disease (PD) Drugs Manufacturers in Global Market, Ranking by Revenue (2021)
Table 11. Global Parkinson's Disease (PD) Drugs Revenue by Manufacturer, (US$ Million), 2017-2022
Table 12. Global Parkinson's Disease (PD) Drugs Revenue Share by Manufacturer, 2017-2022
Table 13. Global Parkinson's Disease (PD) Drugs Sales by Manufacturer, (K Pcs), 2017-2022
Table 14. Global Parkinson's Disease (PD) Drugs Sales Share by Manufacturer, 2017-2022
Table 15. Global Parkinson's Disease (PD) Drugs Price by Manufacturer (2017-2022) & (USD/Pcs)
Table 16. Global Parkinson's Disease (PD) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Parkinson's Disease (PD) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Parkinson's Disease (PD) Drugs as of 2021)
Table 18. Top Players of Parkinson's Disease (PD) Drugs in Global Market, Headquarters and Distribution of Producing Region
Table 19. Manufacturers Parkinson's Disease (PD) Drugs Product Type
Table 20. Date of International Manufacturers Enter into Parkinson's Disease (PD) Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Top Parkinson's Disease (PD) Drugs Players in United States Market, Ranking by Revenue (2021)
Table 23. United States Parkinson's Disease (PD) Drugs Revenue by Players, (US$ Million), 2020, 2021 & 2022
Table 24. United States Parkinson's Disease (PD) Drugs Revenue Share by Players, 2020, 2021 & 2022
Table 25. United States Parkinson's Disease (PD) Drugs Sales by Players, (K Pcs), 2020, 2021 & 2022
Table 26. United States Parkinson's Disease (PD) Drugs Sales Share by Players, 2020, 2021 & 2022
Table 27. Global Parkinson's Disease (PD) Drugs Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
Table 28. Global Parkinson's Disease (PD) Drugs Sales in Volume by Region (2017-2022) & (K Pcs)
Table 29. Global Parkinson's Disease (PD) Drugs Sales in Volume Forecast by Region (2023-2028) & (K Pcs)
Table 30. Global Parkinson's Disease (PD) Drugs Sales in Value by Region (2017-2022) & (US$ Million)
Table 31. Global Parkinson's Disease (PD) Drugs Sales in Value Forecast by Region (2023-2028) & (US$ Million)
Table 32. North America Parkinson's Disease (PD) Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 33. North America Parkinson's Disease (PD) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 34. Asia Pacific Parkinson's Disease (PD) Drugs Sales in Volume by Region (2017-2028) & (K Pcs)
Table 35. Asia Pacific Parkinson's Disease (PD) Drugs Sales in Value by Region (2017-2028) & (US$ Million)
Table 36. Europe Parkinson's Disease (PD) Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 37. Europe Parkinson's Disease (PD) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 38. Latin America Parkinson's Disease (PD) Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 39. Latin Americaa Parkinson's Disease (PD) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 40. Middle East and Africa Parkinson's Disease (PD) Drugs Sales in Volume by Country (2017-2028) & (K Pcs)
Table 41. Middle East and Africa Parkinson's Disease (PD) Drugs Sales in Value by Country (2017-2028) & (US$ Million)
Table 42. Boehringer Ingelheim Corporation Information
Table 43. Boehringer Ingelheim Description and Business Overview
Table 44. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 45. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product
Table 46. Boehringer Ingelheim Recent Development
Table 47. GlaxoSmithKline Corporation Information
Table 48. GlaxoSmithKline Description and Business Overview
Table 49. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 50. GlaxoSmithKline Product
Table 51. GlaxoSmithKline Recent Development
Table 52. Novartis Corporation Information
Table 53. Novartis Description and Business Overview
Table 54. Novartis Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 55. Novartis Product
Table 56. Novartis Recent Development
Table 57. Teva Pharmaceutical Industries Corporation Information
Table 58. Teva Pharmaceutical Industries Description and Business Overview
Table 59. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 60. Teva Pharmaceutical Industries Product
Table 61. Teva Pharmaceutical Industries Recent Development
Table 62. AbbVie Corporation Information
Table 63. AbbVie Description and Business Overview
Table 64. AbbVie Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 65. AbbVie Product
Table 66. AbbVie Recent Development
Table 67. Abital Pharma Corporation Information
Table 68. Abital Pharma Description and Business Overview
Table 69. Abital Pharma Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 70. Abital Pharma Product
Table 71. Abital Pharma Recent Development
Table 72. Addex Therapeutics Corporation Information
Table 73. Addex Therapeutics Description and Business Overview
Table 74. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 75. Addex Therapeutics Product
Table 76. Addex Therapeutics Recent Development
Table 77. Biogen Corporation Information
Table 78. Biogen Description and Business Overview
Table 79. Biogen Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 80. Biogen Product
Table 81. Biogen Recent Development
Table 82. Eisai Corporation Information
Table 83. Eisai Description and Business Overview
Table 84. Eisai Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 85. Eisai Product
Table 86. Eisai Recent Development
Table 87. Eli Lilly Corporation Information
Table 88. Eli Lilly Description and Business Overview
Table 89. Eli Lilly Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 90. Eli Lilly Product
Table 91. Eli Lilly Recent Development
Table 92. F. Hoffmann-La Roche Corporation Information
Table 93. F. Hoffmann-La Roche Description and Business Overview
Table 94. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 95. F. Hoffmann-La Roche Product
Table 96. F. Hoffmann-La Roche Recent Development
Table 97. H. Lundbeck Corporation Information
Table 98. H. Lundbeck Description and Business Overview
Table 99. H. Lundbeck Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 100. H. Lundbeck Product
Table 101. H. Lundbeck Recent Development
Table 102. Impax Laboratories Corporation Information
Table 103. Impax Laboratories Description and Business Overview
Table 104. Impax Laboratories Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 105. Impax Laboratories Product
Table 106. Impax Laboratories Recent Development
Table 107. Kyowa Hakko Kirin Corporation Information
Table 108. Kyowa Hakko Kirin Description and Business Overview
Table 109. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 110. Kyowa Hakko Kirin Product
Table 111. Kyowa Hakko Kirin Recent Development
Table 112. Otsuka Pharmaceutical Corporation Information
Table 113. Otsuka Pharmaceutical Description and Business Overview
Table 114. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 115. Otsuka Pharmaceutical Product
Table 116. Otsuka Pharmaceutical Recent Development
Table 117. Pfizer Corporation Information
Table 118. Pfizer Description and Business Overview
Table 119. Pfizer Parkinson's Disease (PD) Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 120. Pfizer Product
Table 121. Pfizer Recent Development
Table 122. Key Raw Materials Lists
Table 123. Raw Materials Key Suppliers Lists
Table 124. Parkinson's Disease (PD) Drugs Customers List
Table 125. Parkinson's Disease (PD) Drugs Distributors List
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Parkinson's Disease (PD) Drugs Product Picture
Figure 2. Global Parkinson's Disease (PD) Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 3. Global Parkinson's Disease (PD) Drugs Market Size 2017-2028 (US$ Million)
Figure 4. Global Parkinson's Disease (PD) Drugs Sales 2017-2028 (K Pcs)
Figure 5. United States Parkinson's Disease (PD) Drugs Revenue, (US$ Million), 2017 VS 2022 VS 2028
Figure 6. United States Parkinson's Disease (PD) Drugs Market Size 2017-2028 (US$ Million)
Figure 7. United States Parkinson's Disease (PD) Drugs Sales 2017-2028 (K Pcs)
Figure 8. United States Parkinson's Disease (PD) Drugs Market Share in Global, in Value (US$ Million) 2017-2028
Figure 9. United States Parkinson's Disease (PD) Drugs Market Share in Global, in Volume (K Pcs) 2017-2028
Figure 10. Parkinson's Disease (PD) Drugs Report Years Considered
Figure 11. Product Picture of Dopamine Agonist
Figure 12. Product Picture of Monoamine Oxidase Inhibitors
Figure 13. Product Picture of Acetylcholinesterase Inhibitors
Figure 14. Product Picture of Glutamate Inhibitors
Figure 15. Global Parkinson's Disease (PD) Drugs Market Share by Type in 2022 & 2028
Figure 16. Global Parkinson's Disease (PD) Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 17. Global Parkinson's Disease (PD) Drugs Sales Market Share in Value by Type (2017-2028)
Figure 18. Global Parkinson's Disease (PD) Drugs Sales by Type (2017-2028) & (K Pcs)
Figure 19. Global Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 20. Global Parkinson's Disease (PD) Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 21. United States Parkinson's Disease (PD) Drugs Market Share by Type in 2022 & 2028
Figure 22. United States Parkinson's Disease (PD) Drugs Sales in Value by Type (2017-2028) & (US$ Million)
Figure 23. United States Parkinson's Disease (PD) Drugs Sales Market Share in Value by Type (2017-2028)
Figure 24. United States Parkinson's Disease (PD) Drugs Sales by Type (2017-2028) & (K Pcs)
Figure 25. United States Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Type (2017-2028)
Figure 26. United States Parkinson's Disease (PD) Drugs Price by Type (2017-2028) & (USD/Pcs)
Figure 27. Product Picture of Hospital
Figure 28. Product Picture of Family
Figure 29. Global Parkinson's Disease (PD) Drugs Market Share by Application in 2022 & 2028
Figure 30. Global Parkinson's Disease (PD) Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 31. Global Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application (2017-2028)
Figure 32. Global Parkinson's Disease (PD) Drugs Sales by Application (2017-2028) & (K Pcs)
Figure 33. Global Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 34. Global Parkinson's Disease (PD) Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 35. United States Parkinson's Disease (PD) Drugs Market Share by Application in 2022 & 2028
Figure 36. United States Parkinson's Disease (PD) Drugs Sales in Value by Application (2017-2028) & (US$ Million)
Figure 37. United States Parkinson's Disease (PD) Drugs Sales Market Share in Value by Application (2017-2028)
Figure 38. United States Parkinson's Disease (PD) Drugs Sales by Application (2017-2028) & (K Pcs)
Figure 39. United States Parkinson's Disease (PD) Drugs Sales Market Share in Volume by Application (2017-2028)
Figure 40. United States Parkinson's Disease (PD) Drugs Price by Application (2017-2028) & (USD/Pcs)
Figure 41. North America Parkinson's Disease (PD) Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 42. North America Parkinson's Disease (PD) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 43. U.S. Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 44. Canada Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 45. Europe Parkinson's Disease (PD) Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 46. Europe Parkinson's Disease (PD) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 47. Germany Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 48. France Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 49. U.K. Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 50. Italy Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 51. Russia Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 52. Asia-Pacific Parkinson's Disease (PD) Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 53. Asia-Pacific Parkinson's Disease (PD) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 54. China Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 55. Japan Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 56. South Korea Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 57. India Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 58. Australia Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 59. Taiwan Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 60. Indonesia Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 61. Thailand Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 62. Malaysia Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 63. Philippines Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 64. Latin America Parkinson's Disease (PD) Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 65. Latin America Parkinson's Disease (PD) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 66. Mexico Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 67. Brazil Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 68. Argentina Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 69. Middle East & Africa Parkinson's Disease (PD) Drugs Sales in Volume Growth Rate 2017-2028 (K Pcs)
Figure 70. Middle East & Africa Parkinson's Disease (PD) Drugs Sales in Value Growth Rate 2017-2028 (US$ Million)
Figure 71. Turkey Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 72. Saudi Arabia Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 73. UAE Parkinson's Disease (PD) Drugs Sales in Value Growth Rate (2017-2028) & (US$ Million)
Figure 74. Parkinson's Disease (PD) Drugs Value Chain
Figure 75. Parkinson's Disease (PD) Drugs Production Process
Figure 76. Channels of Distribution
Figure 77. Distributors Profiles
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
